Antenatal phenobarbitone and neonatal outcome.
Doyle
L
L
Department of Obstetrics and Gynaecology, Royal Woman's Hospital, Carlton, Victoria, Australia.
D000284:Administration, Oral; D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000517:prevention & control; D002657:Child Development; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010634:Phenobarbital / Q000008:administration & dosage / Q000627:therapeutic use*; D011247:Pregnancy; D011256:Pregnancy Outcome; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D000927:Anticonvulsants; D010634:Phenobarbital